Characterization of human cellular immune responses toMycobacterium tuberculosisproteins encoded by genes predicted in RD15 genomic region that is absent inMycobacterium bovisBCG
Open Access
- 1 July 2010
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 59 (2) , 177-187
Abstract
RD15 is a genomic region of difference (RD) present in Mycobacterium tuberculosis H37Rv but absent in all strains of Mycobacterium bovis BCG. RD15 contains genes encoding proteins of mammalian cell entry (Mce3A-F), important for the invasion and survival of M. tuberculosis in host cells. In this study, we have evaluated cellular immune responses to RD15 proteins using peripheral blood mononuclear cells (PBMC) from pulmonary tuberculosis patients and M. bovis BCG-vaccinated healthy subjects. PBMC were tested for T-helper (Th) type 1 [antigen-induced proliferation and interferon (IFN)-γ secretion] and anti-inflammatory [interleukin (IL)-10 secretion] responses to complex mycobacterial antigens and peptides corresponding to proteins of RD1 and RD15. In Th1 assays, complex mycobacterial antigens induced strong responses in both donor groups, and RD1 induced strong responses in tuberculosis patients and moderate responses in healthy subjects, whereas RD15 induced weak responses in tuberculosis patients and strong to moderate responses in healthy subjects. IL-10 secretion in both donor groups was strong to moderate in response to complex mycobacterial antigens, but weak in response to RD1 and RD15. Analysis of IFN-γ : IL-10 ratios showed strong Th1 biases to complex mycobacterial antigens and RD1 in both donor groups, and to RD15 and RD1504 (Mce3A) in healthy subjects only. These results suggest that RD1504 is the best Th1-stimulating antigen present in RD15, and therefore may be a potential vaccine candidate against TB.Keywords
This publication has 44 references indexed in Scilit:
- Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients andMycobacterium bovisbacilli Calmette–Guérin (BCG)-vaccinated healthy subjectsClinical and Experimental Immunology, 2009
- Characterization of Human Cellular Immune Responses to NovelMycobacterium tuberculosisAntigens Encoded by Genomic Regions Absent inMycobacterium bovisBCGInfection and Immunity, 2008
- Efficient Testing of Large Pools of Mycobacterium tuberculosis RD1 Peptides and Identification of Major Antigens and Immunodominant Peptides Recognized by Human Th1 CellsClinical and Vaccine Immunology, 2008
- Mycobacterium tuberculosis strains disrupted in mce3 and mce4 operons are attenuated in miceJournal of Medical Microbiology, 2008
- Ex Vivo Cytokine mRNA Levels Correlate with Changing Clinical Status of Ethiopian TB Patients and their Contacts Over TimePLOS ONE, 2008
- Longitudinal Tracking of Cytokines after Acute Exposure to Tuberculosis: Association of Distinct Cytokine Patterns with Protection and Disease DevelopmentClinical and Vaccine Immunology, 2007
- Dynamic Changes in Pro- and Anti-Inflammatory Cytokine Profiles and Gamma Interferon Receptor Signaling Integrity Correlate with Tuberculosis Disease Activity and Response to Curative TreatmentInfection and Immunity, 2007
- Immunogenicity ofMycobacterium tuberculosisAntigens inMycobacterium bovisBCG-Vaccinated andM. bovis-Infected CattleInfection and Immunity, 2006
- Assessment ofin vitroimmunity toM ycobacterium tuberculosisin a human peripheral blood infection model using a luciferase reporter construct ofM. tuberculosisH37RvClinical and Experimental Immunology, 2006
- Bacille Calmette-Guerin Vaccine--Induced Disease in HIV-Infected and HIV-Uninfected ChildrenClinical Infectious Diseases, 2006